Key facts
- It has raised $20.8M; the latest was Later Stage VC ($8.1M) in Nov 2025.
- Notable investors include Plug and Play Tech Center, Alumni Ventures, StartX (US), Neer Venture Partners, Mir Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for ISOVive
- ·The full record, as it builds
Funding rounds
No funding rounds for ISOVive are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ISOVive
Developer of prebiotic dietary ingredients designed to support gut health in humans and animals. The company produces zero-calorie, soluble fibers through a proprietary fermentation process that nourish beneficial gut bacteria without adding calories, enabling manufacturers to offer products that promote digestive wellness and metabolic health to food, beverage, and supplement consumers.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Manassas, VA, United States
- Founded
- 2013
- Employees
- 10
- Website
- isovive.com/
- Ownership
- Privately Held (backing)
ISOVive doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ISOVive shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ISOVive in its N-PORT filings yet. We sweep new filings monthly.